Skybiotech Healthcare approves FY26 financials, appoints new auditor
- Skybiotech Healthcare approved standalone and consolidated FY26 financials at its 43rd AGM
- Shareholders appointed M/s. SPD & Associates as the new statutory auditor
- Mr. Prakashchandra Rathi re-appointed as director upon retirement by rotation

*this image is generated using AI for illustrative purposes only.
Skybiotech Healthcare approved its audited financial statements for FY26 during its 43rd Annual General Meeting (AGM) held on September 30, 2026. The meeting also ratified the appointment of M/s. SPD & Associates as the company's statutory auditor.
Key resolutions passed
Shareholders adopted both standalone and consolidated audited financial statements along with the reports of the Board and Auditor for the year ended March 31, 2026. Additionally, Mr. Prakashchandra Rathi was re-appointed as a director, retiring by rotation and offering himself for re-appointment as he is eligible.
The AGM concluded at 12:40 pm on September 30, 2026, at the company's registered office in Chh. Sambhaji Nagar, Maharashtra.
Audit and governance updates
The appointment of M/s. SPD & Associates, Chartered Accountants (FRN: 139118W), marks a change in the statutory audit engagement for the company. This resolution was passed as an ordinary resolution by the members present.
| Resolution Type | Matter | Status |
|---|---|---|
| Ordinary | Adoption of Standalone Audited Financial Statements (FY26) | Approved |
| Ordinary | Adoption of Consolidated Audited Financial Statements (FY26) | Approved |
| Ordinary | Re-appointment of Mr. Prakashchandra Rathi as Director | Approved |
| Ordinary | Appointment of SPD & Associates as Statutory Auditor | Approved |
Corporate background
Skybiotech Healthcare Limited, formerly known as Kapil Cotex Ltd, operates under the leadership of Managing Director Poonam Prakash Rathi. The company filed its corporate announcement with BSE Limited detailing these outcomes.
Historical Stock Returns for Skybiotech Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.55% | +2.56% | -9.09% | 0.0% | -44.65% | 0.0% |
How will the change in statutory auditor to SPD & Associates potentially impact the transparency and rigor of Skybiotech Healthcare's future financial reporting?
What strategic initiatives is Skybiotech Healthcare planning to leverage its transition from Kapil Cotex Ltd to the healthcare sector in FY27?
How might the re-appointment of Mr. Prakashchandra Rathi influence the company's corporate governance standards and long-term shareholder value?































